PEN - Utang jangka dawa perusahaan Penumbra Corp

Partnerships with clinics to implement thrombectomy systems have driven growth for Penumbra, Inc. (PEN). The business's long-term debt metric reflects loan dynamics, where 0.19 is the current value of the indicator. Penumbra, Inc. (PEN) generates revenue through B2B supplies of aspiration catheters to hospitals, while the high scalability of innovative device production contributes to a steady increase in net margin.

Scaling the production of high-margin catheters at Penumbra, Inc. (PEN) requires significant capital expenditures in its technological base. This metric captures the total volume of liabilities with a maturity of more than one year, reflecting the issuer's long-term debt load. An increase in this metric indicates expansion through borrowing, while a decrease signals strengthened financial autonomy. By analyzing the trend of the corporation's long-term loans and borrowings, an investor can assess the business's resilience to market shocks.